Yuichi Terawaki

565 total citations
13 papers, 422 citations indexed

About

Yuichi Terawaki is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Yuichi Terawaki has authored 13 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Yuichi Terawaki's work include Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diabetes Management and Research (4 papers). Yuichi Terawaki is often cited by papers focused on Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diabetes Management and Research (4 papers). Yuichi Terawaki collaborates with scholars based in Japan and United States. Yuichi Terawaki's co-authors include Takashi Nomiyama, Makito Tanabe, Toshihiko Yanase, Yuriko Hamaguchi, Tomoko Tanaka, Takako Kawanami, Ryoko Motonaga, Yoko Tsutsumi, Hiroyuki Takahashi and Kazuki Nabeshima and has published in prestigious journals such as PLoS ONE, Diabetes and Endocrinology.

In The Last Decade

Yuichi Terawaki

13 papers receiving 421 citations

Peers

Countries citing papers authored by Yuichi Terawaki

Since Specialization

Citations

This map shows the geographic impact of Yuichi Terawaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Terawaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Terawaki more than expected).

Fields of papers citing papers by Yuichi Terawaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Terawaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Terawaki. The network helps show where Yuichi Terawaki may publish in the future.

Co-authorship network of co-authors of Yuichi Terawaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Terawaki. A scholar is included among the top collaborators of Yuichi Terawaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Terawaki. Yuichi Terawaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F) 2020 ·Diabetology International ·(unknown), Yuichi Terawaki, (unknown), Takashi Nomiyama, Dai Shimono, Tsuyoshi Horikawa, (unknown), Toru Shigeoka, (unknown), Ryoko Motonaga, Makito Tanabe, Toshihiko Yanase, Daiji Kawanami	1
2	Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice 2019 ·Biochemistry and Biophysics Reports ·Hiroyuki Takahashi, Takashi Nomiyama, Yuichi Terawaki, (unknown), Takako Kawanami, Yuriko Hamaguchi, Tomoko Tanaka, Ryoko Motonaga, Takashi Fukuda, Makito Tanabe, Toshihiko Yanase	41
3	GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells 2018 ·Journal of Atherosclerosis and Thrombosis ·Hiroyuki Takahashi, Takashi Nomiyama, Yuichi Terawaki, Takako Kawanami, Yuriko Hamaguchi, Tomoko Tanaka, Makito Tanabe, Dennis Bruemmer, Toshihiko Yanase	18
4	Efficacy and safety of sodium–glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION) 2018 ·Endocrine Journal ·Takashi Nomiyama, Dai Shimono, Tsuyoshi Horikawa, Yuki Fujimura, (unknown), Yuichi Terawaki, Takashi Fukuda, Ryoko Motonaga, Makito Tanabe, Toshihiko Yanase, (unknown)	20
5	Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation 2017 ·Endocrinology ·(unknown), Takashi Nomiyama, (unknown), Takako Kawanami, Yoko Tsutsumi, Yuriko Hamaguchi, Tsuyoshi Horikawa, Yasuteru Yoshinaga, Shin-ichi Yamashita, Tomoko Tanaka, Yuichi Terawaki, Makito Tanabe, Kazuki Nabeshima, Akinori Iwasaki, Toshihiko Yanase	62
6	A Probable Case of Burn-out NASH Caused by PanhypopituitarismSecondary to Craniopharyngioma. 2016 ·PubMed ·Yuichi Terawaki, (unknown), Ryoko Motonaga, Makito Tanabe, Takashi Nomiyama, Satoshi Shakado, (unknown), Shotaro Sakisaka, Toshihiko Yanase	2
7	Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database 2016 ·Journal of Diabetes Investigation ·Makito Tanabe, Ryoko Motonaga, Yuichi Terawaki, Takashi Nomiyama, Toshihiko Yanase	40
8	Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis 2015 ·Diabetology & Metabolic Syndrome ·Yuichi Terawaki, Takashi Nomiyama, Hiroyuki Takahashi, Yoko Tsutsumi, (unknown), (unknown), Makito Tanabe, (unknown), Kunihisa Kobayashi, Tetsuhiko Yasuno, Hitoshi Nakashima, Toshihiko Yanase	19
9	Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth 2015 ·PLoS ONE ·Yoko Tsutsumi, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Yuichi Terawaki, Tomoko Tanaka, (unknown), Ryoko Motonaga, Makito Tanabe, Toshihiko Yanase	39
10	Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury 2014 ·Cardiovascular Diabetology ·Yuichi Terawaki, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Hiroyuki Takahashi, Tomoko Tanaka, (unknown), (unknown), Makito Tanabe, Toshihiko Yanase	44
11	A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration 2014 ·Meta Gene ·Kumiko Ohkubo, (unknown), (unknown), Ryoko Yoshida, Yuichi Terawaki, Akira Maeyama, (unknown), Junko Ono, Toshihiko Yanase, Akira Matsunaga	5
12	Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth 2014 ·Diabetes ·Takashi Nomiyama, Takako Kawanami, Shinichiro Irie, Yuriko Hamaguchi, Yuichi Terawaki, (unknown), Yoko Tsutsumi, (unknown), Makito Tanabe, Hidetaka Morinaga, Tomoko Tanaka, (unknown), Kazuki Nabeshima, Masatoshi Tanaka, Toshihiko Yanase	107
13	The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis 2013 ·Diabetology & Metabolic Syndrome ·Yuichi Terawaki, Takashi Nomiyama, Yuko Akehi, (unknown), (unknown), Yoko Tsutsumi, (unknown), (unknown), (unknown), Kaoru Sugimoto, Ayako Takada, Kenji Ito, Yasuhiro Abe, Yoshie Sasatomi, Satoru Ogahara, Hitoshi Nakashima, Takao Saito, Toshihiko Yanase	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact